skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Helical synthetic peptides that stimulate cellular cholesterol efflux

Patent ·
OSTI ID:1176216
;

The present invention provides peptides comprising at least one amphipathic alpha helix and having an cholesterol mediating activity and a ABCA stabilization activity. The invention further provides methods of using such peptides.

Research Organization:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC03-76SF00098
Assignee:
The Regents of the University of California (Oakland, CA)
Patent Number(s):
7,691,965
Application Number:
11/014,187
OSTI ID:
1176216
Resource Relation:
Patent File Date: 2004 Dec 15
Country of Publication:
United States
Language:
English

References (38)

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease journal August 1999
High-density lipoprotein cholesterol and coronary artery disease: Survey of the evidence journal September 1990
The replacement of arginine by cysteine at residue 151 in Apolipoprotein A-I produces a phenotype similar to that of Apolipoprotein A-I Milano journal January 1997
Thiol-bearing synthetic peptides retain the antioxidant activity of apolipoproteinA-IMilano journal September 2002
The Hydrophobic Face Orientation of Apolipoprotein A-I Amphipathic Helix Domain 143–164 Regulates Lecithin:Cholesterol Acyltransferase Activation journal May 1998
High-density lipoprotein, low-density lipoprotein and coronary artery disease journal September 1990
Specific Binding of ApoA-I, Enhanced Cholesterol Efflux, and Altered Plasma Membrane Morphology in Cells Expressing ABC1 journal July 2000
Only the Two End Helixes of Eight Tandem Amphipathic Helical Domains of Human Apo A-I Have Significant Lipid Affinity: Implications for HDL Assembly journal February 1996
Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. journal October 1994
Helical Apolipoproteins Stabilize ATP-binding Cassette Transporter A1 by Protecting It from Thiol Protease-mediated Degradation journal April 2002
Phosphorylation of a Pest Sequence in ABCA1 Promotes Calpain Degradation and Is Reversed by ApoA-I journal July 2003
Thematic review series: The Pathogenesis of Atherosclerosis The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL journal April 2004
Apolipoprotein A-IGiessen (Pro143Arg). A mutant that is defective in activating lecithin:cholesterol acyltransferase journal October 1984
Effects of Recombinant Apolipoprotein A-I Milano on Aortic Atherosclerosis in Apolipoprotein E–Deficient Mice journal March 1998
High-Dose Recombinant Apolipoprotein A-I Milano Mobilizes Tissue Cholesterol and Rapidly Reduces Plaque Lipid and Macrophage Content in Apolipoprotein E–Deficient Mice: Potential Implications for Acute Plaque Stabilization journal June 2001
Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins journal July 2004
Alteration in Apolipoprotein A-I 22-Mer Repeat Order Results in a Decrease in Lecithin:Cholesterol Acyltransferase Reactivity journal March 1997
A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I journal January 2003
ATP-Binding Cassette Transporter A1 (ABCA1) in Macrophages: A Dual Function in Inflammation and Lipid Metabolism? journal January 1999
Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. journal July 1995
Cysteine Substitutions in Apolipoprotein A-I Primary Structure Modulate Paraoxonase Activity † journal February 2001
ATP-Binding Cassette Transporter 1 Participates in LDL Oxidation by Artery Wall Cells journal November 2002
A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins. journal November 1980
A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. journal November 1980
Apolipoprotein-mediated Plasma Membrane Microsolubilization: ROLE OF LIPID AFFINITY AND MEMBRANE PENETRATION IN THE EFFLUX OF CELLULAR CHOLESTEROL AND PHOSPHOLIPID journal January 1999
Studies of Synthetic Peptides of Human Apolipoprotein A-I Containing Tandem Amphipathic α-Helixes † journal July 1998
Identification of an Apolipoprotein A-I Structural Element That Mediates Cellular Cholesterol Efflux and Stabilizes ATP Binding Cassette Transporter A1 journal March 2004
Aromatic Residue Position on the Nonpolar Face of Class A Amphipathic Helical Peptides Determines Biological Activity journal April 2004
High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1 journal April 2000
Domain Structure and Lipid Interaction in Human Apolipoproteins A-I and E, a General Model journal April 2003
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency journal August 1999
Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits. journal October 1994
Protein Folding: A Glimpse of the Holy Grail? journal October 1998
Metabolism of apolipoproteins AI and AII in subjects carrying similar apoAI mutations, apoAI Milano and apoAI Paris journal February 2000
Apolipoprotein A-I Milano and Apolipoprotein A-I Paris Exhibit an Antioxidant Activity Distinct from That of Wild-Type Apolipoprotein A-I † journal February 2002
The Central Helices of ApoA-I Can Promote ATP-binding Cassette Transporter A1 (ABCA1)-mediated Lipid Efflux: AMINO ACID RESIDUES 220–231 OF THE WILD-TYPE ApoA-I ARE REQUIRED FOR LIPID EFFLUX IN VITRO AND HIGH DENSITY LIPOPROTEIN FORMATION IN VIVO journal December 2002
Cardiovascular Status of Carriers of the Apolipoprotein A-I Milano Mutant: The Limone sul Garda Study journal April 2001
Decreased Reverse Cholesterol Transport from Tangier Disease Fibroblasts: Acceptor Specificity and Effect of Brefeldin on Lipid Efflux journal September 1997

Similar Records

Related Subjects

59 BASIC BIOLOGICAL SCIENCES
60 APPLIED LIFE SCIENCES